Sodium 5-(2-carbamoylhydrazineylidene)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate trihydrate

Catalog No. :
ACVBIK738
CAS No. :
2666934-58-1
Molecular Formula :
C10H17N4NaO8S
Molecular Weight :
376.32

IUPAC Name:sodium 5-(2-carbamoylhydrazineylidene)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate trihydrate

Sodium 5-(2-carbamoylhydrazineylidene)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate trihydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$136.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium 5-(2-carbamoylhydrazineylidene)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate trihydrate
IUPAC Namesodium 5-(2-carbamoylhydrazineylidene)-1-methyl-6-oxo-2,3,5,6-tetrahydro-1H-indole-2-sulfonate trihydrate
MDL No.MFCD00211294
Molecular FormulaC10H17N4NaO8S
Molecular Weight376.32
SMILESO=S(C(CC1=CC2=NNC(N)=O)N(C)C1=CC2=O)([O-])=O.[H]O[H].[H]O[H].[H]O[H].[Na+]
InChI KeyCQGHBSBJJFZEHQ-UHFFFAOYSA-M
CAS No.2666934-58-1

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H318
Precautionary Statement(s)
P264-P270-P280-P301+P312-P305+P351+P338-P310-P330-P501

Synthetic Route by SureRoute

1. ACVBIK738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWLUP957 route compound structure diagram
    ACWLUP95757-56-7 In Stock
  4. Then
  5. ACVBIK738 route product structure diagram
    ACVBIK7382666934-58-1 In Stock
Inquiry

2. ACVBIK738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVBIK738 route product structure diagram
    ACVBIK7382666934-58-1 In Stock
Inquiry

Comments (0)